Cite

HARVARD Citation

    Ren, H. et al. (2022). RAB26 contributes to the progression of non-small cell lung cancer after being transcriptionally activated by SMAD3. Bioengineered. 13 (4), pp. 8064-8075. [Online]. 
  
Back to record